0.9689560908	phenylalanine hydroxylase
0.9676175063	duchenne muscular dystrophy
0.9674522214	ionizing radiation
0.9674253919	familial adenomatous polyposis
0.9672312056	amino acids
0.9667151373	amino acid
0.9661465108	familial mediterranean fever
0.9652609819	prader willi syndrome
0.9650961622	renal cell carcinoma
0.9636844381	metachromatic leukodystrophy
0.9635212323	pelizaeus merzbacher disease
0.9631821041	denys drash syndrome
0.9629574481	ankylosing spondylitis
0.9629230808	color vision
0.9625305560	mental retardation
0.9624451470	reading frame
0.9624263810	beta catenin
0.9620880076	wild type
0.9613019547	myotonic dystrophy
0.9607751471	adenomatous polyposis coli
0.9606313328	friedreich ataxia
0.9605669706	wiskott aldrich syndrome
0.9598875106	cell cycle
0.9596602512	autosomal dominant
0.9596490496	ataxia telangiectasia
0.9593989664	rt pcr
0.9590910808	zinc finger
0.9589657228	hearing loss
0.9588086254	kniest dysplasia
0.9574547185	gel electrophoresis
0.9570475421	van der woude syndrome
0.9560475195	ashkenazi jewish
0.9559848326	huntington disease
0.9549971215	wilson disease
0.9549625814	polymerase chain reaction
0.9541230836	diastrophic dysplasia
0.9538787073	messenger rna
0.9532805297	machado joseph disease
0.9532421270	hemolytic anemia
0.9500504346	glucose 6 phosphate dehydrogenase
0.9460358781	linkage disequilibrium
0.9456211342	von willebrand factor
0.9451046325	prostate cancer
0.9441610626	pendred syndrome
0.9440701025	ovarian cancer
0.9439849241	prenatal diagnosis
0.9424260659	tay sachs disease
0.9387031229	confidence interval
0.9385012550	breast cancer
0.9362012910	animal model
0.9356055762	uniparental disomy
0.9340900467	autosomal recessive
0.9326515127	muscular dystrophy
0.9318641954	diabetes mellitus
0.9268869927	von willebrand disease
0.9250810753	cell line
0.9246311266	norrie disease
0.9238225453	french canadian
0.9218240262	dna damage
0.9216119112	base pair
0.9200706468	tumor suppressor
0.9199291116	diabetes insipidus
0.9166228626	cholesteryl ester transfer protein
0.9149361177	beta oxidation
0.9135437650	colorectal cancer
0.9129219483	mg dl
0.9117540937	emery dreifuss muscular dystrophy
0.9115433330	missense mutations
0.9115265067	segregation distortion
0.9098977067	cell lines
0.9085302180	southern blot
0.9081208456	becker muscular dystrophy
0.9079228144	skeletal muscle
0.9045261782	fluorescence in situ hybridization
0.9015206237	fatty acids
0.8984955315	renal cell carcinomas
0.8973588527	neurohypophyseal diabetes insipidus
0.8953700213	cerebrotendinous xanthomatosis
0.8928083100	lysosomal storage
0.8915213589	lod score
0.8899534337	point mutations
0.8860499028	mps iva
0.8806276846	missense mutation
0.8803285175	15q11 q13
0.8771347808	protein kinase
0.8759113849	genotype phenotype correlations
0.8758735680	pax3 fkhr
0.8724895443	c9 deficiency
0.8673044918	wilms tumor
0.8660781819	founder effect
0.8637441392	premature termination
0.8595675585	germ line
0.8576842495	gastric cancer
0.8532589510	von hippel lindau
0.8529329536	lesch nyhan
0.8480118712	tumour suppressor
0.8464765666	canavan disease
0.8462650284	genetic counseling
0.8440609875	transgenic mice
0.8378830729	ctg repeat
0.8369661665	lesch nyhan syndrome
0.8354349005	somatic cell hybrids
0.8345073696	alpha subunit
0.8318797262	c2 deficiency
0.8261926219	tay sachs
0.8260497935	peripheral blood
0.8258875314	direct sequencing
0.8244441186	nuclear membrane
0.8242791868	acyl coa
0.8223527109	cag repeat
0.8214994887	genetic linkage
0.8214510611	stop codon
0.8205873849	coding sequence
0.8204105189	family members
0.8184266330	tumor suppressor gene
0.8110885731	adult onset
0.8030595754	highly conserved
0.8009517580	ovarian cancers
0.8002307111	skin fibroblasts
0.7975559330	linkage analysis
0.7964935990	galactose 1 phosphate
0.7949907443	fragile x syndrome
0.7925583687	von willebrand
0.7917782080	cholesteryl ester
0.7890370823	dna sequencing
0.7883619243	dna sequence
0.7876899681	prader willi
0.7853780153	frameshift mutation
0.7853777743	transcription factor
0.7817557957	single strand conformation polymorphism
0.7809980280	coding region
0.7804132262	somatic cell
0.7767800176	type ii
0.7741333225	genetic disorder
0.7661456024	proteolipid protein
0.7653433630	lod scores
0.7653057349	genomic dna
0.7646757236	nonsense mutation
0.7598445578	vlcad deficiency
0.7586604886	breast and ovarian cancer
0.7578567632	point mutation
0.7555357732	tightly linked
0.7554127496	late infantile
0.7547449964	sequence analysis
0.7544694641	clinical manifestations
0.7540043170	pelizaeus merzbacher
0.7530435378	splice donor site
0.7525502267	compound heterozygotes
0.7522849540	c3 deficiency
0.7522784604	closely linked
0.7496280862	membrane protein
0.7491866388	vwf ag
0.7439063030	splice site
0.7431974807	dominant negative
0.7418263275	g6pd deficiency
0.7397514411	amino acid substitutions
0.7378452320	cerebral ald
0.7351921066	early onset
0.7345855851	sulfate transporter
0.7339480432	carrier status
0.7337816093	growth factor
0.7332579392	coa dehydrogenase
0.7316481336	late onset
0.7298451572	donor splice site
0.7295813690	hypoxanthine guanine
0.7283151023	heteroduplex analysis
0.7258332549	hdl cholesterol
0.7244408652	ethnic groups
0.7232975216	africa
0.7219545374	clinical features
0.7213473201	genetic analysis
0.7188823993	g6pd mediterranean
0.7185031680	japanese and caucasian
0.7181758872	very long chain acyl
0.7158532850	splice acceptor
0.7147733725	adenomatous polyposis
0.7139908655	dutch
0.7120510142	glycerol
0.7119704804	melanoma
0.7092341073	spinal
0.7092009654	eastern
0.7086476704	irish
0.7085737440	arthritis
0.7077414215	analysis revealed
0.7073249572	previously identified
0.7069990148	genetic heterogeneity
0.7064892659	consensus
0.7055146281	enzymatic activity
0.7054259275	europe
0.7049585089	binding domain
0.7047121070	mass
0.7039753618	biopsy
0.7028842267	british
0.7027942741	culture
0.7017701983	termination codon
0.7014312068	mucopolysaccharidosis
0.7007940056	pancreatic
0.7007940056	idiopathic
0.7002966761	affected individuals
0.6999146888	carrier detection
0.6991610321	behavioral
0.6990227780	red
0.6983626291	microsatellite markers
0.6977318772	histocompatibility
0.6971740616	leukemia
0.6970136813	macular
0.6968815052	chloride
0.6966424780	antibodies
0.6964831035	bacterial
0.6964831035	field
0.6962373794	genetics
0.6960483550	differential
0.6958946055	component of complement
0.6957698286	cag repeats
0.6952815723	high density
0.6949909354	neuronal
0.6949679096	lip
0.6944640069	neonatal
0.6939927766	c3
0.6924062639	dysfunction
0.6923692094	malignant
0.6919880538	methylation
0.6919213638	previously reported
0.6910735756	visual
0.6910735756	impairment
0.6908505167	neurological
0.6904600643	restriction fragment length
0.6892020351	cognitive
0.6891311086	myotonia
0.6881307394	brca1
0.6877849517	italian
0.6874781286	oral
0.6874175322	caucasian
0.6873805557	metabolic
0.6872980416	very long chain fatty acids
0.6870073151	molecular analysis
0.6869209193	facial
0.6869209193	immunodeficiency
0.6869209193	conformational
0.6863147209	colon
0.6861150863	pigment
0.6859572845	hereditary breast
0.6854748010	embryonic
0.6850916413	hair
0.6850399921	enzymes
0.6848993735	malaria
0.6845898187	japanese
0.6832969096	cysteine
0.6832969096	extracellular
0.6827187169	dystonia
0.6826865260	high frequency
0.6824942761	polymerase chain
0.6824049334	antibody
0.6821366938	assess
0.6821094965	french
0.6808876967	polyps
0.6803749898	targeting
0.6803749898	sensorineural
0.6802741503	meningococcal
0.6802163275	acute
0.6802163275	differentiation
0.6798207986	ashkenazi
0.6793289338	jews
0.6792247446	moroccan
0.6787705486	bone
0.6768751705	premature stop codon
0.6764822887	mouse model
0.6759504437	lymphoma
0.6759246369	cluster
0.6757838604	heart
0.6756809366	gastric
0.6754745868	coa
0.6753530629	milk
0.6752106906	platelet
0.6751750645	selection
0.6748668408	enzyme activity
0.6744229515	nt
0.6744145509	knockout
0.6743014112	guanine
0.6742351953	brca2
0.6738918874	cardiomyopathy
0.6738918874	transmembrane
0.6735575491	na
0.6732024212	mutations
0.6729917136	g6pd
0.6728198537	dna
0.6726208541	variation
0.6726069776	dm kinase
0.6725514112	hypoxanthine
0.6724798164	hereditary hemochromatosis
0.6715585558	homozygosity
0.6715301990	family
0.6713844924	adenomas
0.6713666547	eye
0.6706949258	motif
0.6705299817	brca1 and brca2
0.6705292768	chromosome
0.6704287276	autoimmune
0.6703186053	iodide
0.6703157749	essential
0.6702218928	hypoplasia
0.6700854718	kidney
0.6693848210	chronic
0.6691471203	hormone
0.6685726101	failure
0.6685726101	anomaly
0.6680496790	western
0.6679504997	american
0.6676738302	genome
0.6675886435	splice donor
0.6670870477	phosphorylation
0.6666115862	immune
0.6663844716	iva
0.6663326729	hex
0.6662608094	african
0.6653636417	sulfate
0.6651589697	transporter
0.6645540500	genetic
0.6644251334	exon
0.6643339198	sodium
0.6641852486	alternative
0.6634368654	human
0.6633064829	island
0.6631964127	fact
0.6626708241	mutation
0.6622622165	pax3
0.6619185522	c282y
0.6618528585	neoplasms
0.6618528585	random
0.6612037167	mediterranean
0.6606527811	trinucleotide repeat
0.6606004453	short
0.6605763285	reverse
0.6603501859	insufficiency
0.6599596755	c9
0.6597981764	progression
0.6596619202	ndp
0.6588911302	advantage
0.6587735109	enzymatic
0.6586844786	life
0.6583008904	testing
0.6580122647	sequence
0.6579775912	rna
0.6578643805	southern
0.6577298965	heterozygous
0.6576102884	single strand conformation
0.6575401435	high
0.6574137150	ethnic
0.6574058380	wilms
0.6573339114	examination
0.6571379836	photoreceptor
0.6568518821	channel
0.6567296789	nonsense mutations
0.6566324954	truncating
0.6566172398	generalized
0.6562653051	dinucleotide
0.6557006998	der
0.6555212508	gamma
0.6555212508	affinity
0.6555212508	responses
0.6555212508	anomalies
0.6555212508	area
0.6555212508	double
0.6555212508	myelin
0.6555212508	probability
0.6555212508	actin
0.6554720682	countries
0.6554066522	cohort
0.6553323966	hdl
0.6551737475	diagnostic
0.6551150890	apc
0.6543337390	expression
0.6542208916	results
0.6541780876	pds
0.6541198213	vlcad
0.6536030231	patient
0.6532054870	canadian
0.6530370635	disomy
0.6529953298	c2
0.6528777967	jewish
0.6528282227	cell
0.6527824980	provide evidence
0.6526998071	pairs
0.6524874810	microsatellite
0.6522286431	close linkage
0.6521995258	muscle
0.6520002391	adrenal
0.6519393310	epithelial
0.6518358353	ald
0.6512906545	pcr
0.6510551250	synthesis
0.6508519922	child
0.6504024947	fkhr
0.6502767275	cetp
0.6500570925	determination
0.6500021034	genomic
0.6499710722	reduction
0.6497035546	pax6
0.6495479627	high risk
0.6494894210	white
0.6494792432	type
0.6494585882	infections
0.6494496959	greater
0.6492195255	molecular
0.6491779829	nucleotide position
0.6489622495	cerebellar
0.6488535930	scores
0.6488254821	cleft
0.6485873998	individuals
0.6484626899	homozygous
0.6483985265	ii
0.6483964032	impaired
0.6483222146	fusion
0.6478238344	vhl
0.6477584583	lipoprotein
0.6476133508	c6
0.6475175693	familial
0.6471957912	properties
0.6471136244	ag
0.6467327274	palate
0.6463640853	tumor
0.6460486053	cancer
0.6458672532	wt1
0.6458656095	mice
0.6455479410	mutant
0.6453179095	manifestation
0.6453179095	presenting
0.6450664924	understanding
0.6449531796	atm
0.6445681010	haplotype
0.6445417009	breast ovarian cancer
0.6444874739	hla
0.6442172708	severe
0.6437259951	c7 deficiency
0.6437167946	sensitive
0.6437167946	young
0.6428286287	repair
0.6427460813	c7
0.6426398945	duchenne
0.6425741306	infantile
0.6424260322	tightly
0.6424031878	relationship
0.6423364455	mutation causing
0.6422456349	european
0.6418870801	ct
0.6416229071	clinical
0.6412526452	colorectal
0.6411565944	nature
0.6410865638	heterozygosity
0.6410865638	truncation
0.6408017964	inherited
0.6407296330	studies
0.6407115638	location
0.6406192808	deletion
0.6405415092	electrophoresis
0.6401022226	peptide
0.6401018536	germline
0.6399526567	complement
0.6398653494	acceptor
0.6398252682	population
0.6397927488	study
0.6393945286	affected
0.6390827793	products
0.6390690997	relatives
0.6381328335	protein truncation test
0.6381033695	hd
0.6379961710	dmd
0.6379536111	segregation
0.6379298447	analysis
0.6378371179	hexa
0.6378292274	process
0.6378253199	duplication
0.6377711047	observations
0.6377711047	lysosomal
0.6377582054	attenuated
0.6375456886	common
0.6374352797	wasp
0.6372115049	breast ovarian
0.6363042049	status
0.6363042049	signal
0.6362795584	heterozygote
0.6361809234	degeneration
0.6361156382	rb1
0.6360639849	increased
0.6360097247	protein
0.6354502769	utr
0.6347762690	infection
0.6347309409	pah
0.6344819983	fap
0.6342917675	dm
0.6342352092	somatic
0.6341856032	means
0.6339693751	unrelated families
0.6339627154	chromosomal
0.6336325782	northern
0.6329341353	organization
0.6327959879	appeared
0.6327959879	man
0.6327959879	series
0.6327083445	plp
0.6320313803	patients
0.6319390761	cardiac
0.6319325864	angelman
0.6313236798	data
0.6309170527	adrenoleukodystrophy
0.6308518980	sscp
0.6306438207	cag
0.6302858471	gene
0.6300249972	hybrids
0.6298656050	large
0.6296187955	codon
0.6293730858	spectrum
0.6291601673	linkage
0.6290713499	nucleotide
0.6288996906	peroxisomal
0.6288351953	wide
0.6287600572	cerebral
0.6285771831	dominant
0.6284536136	color
0.6284109683	define
0.6283493681	disease
0.6283065288	ctg
0.6279598182	mg
0.6278981894	active
0.6275323648	molecular genetic
0.6274113104	hprt
0.6269189478	hereditary
0.6266717131	splicing
0.6262947031	male
0.6262076981	recombination
0.6261024910	diagnosis
0.6257709005	long
0.6256612246	oxidation
0.6254273273	phenotype
0.6253755103	fever
0.6253755103	galactose
0.6252678739	families
0.6252540356	mitochondrial
0.6249998638	severe phenotype
0.6248347434	predisposition
0.6248023444	key
0.6248023444	heteroduplex
0.6247483106	screen
0.6247354312	age
0.6244268905	single
0.6241972672	phase
0.6240065852	boy
0.6238440350	frequent
0.6236929369	single strand
0.6235931127	long chain fatty acids
0.6235840046	transfer
0.6235615805	correlated
0.6234808799	evidence
0.6234587560	isolated
0.6234475846	cholesteryl
0.6231292668	breast and or ovarian cancer
0.6227539339	alleles
0.6227140478	mutation detection
0.6224998513	truncating mutations
0.6222427466	skin
0.6222286988	founder
0.6221296018	nucleotide sequence
0.6214870001	g6pd variants
0.6213265766	samples
0.6212025919	similar
0.6207396184	mouse
0.6207145753	survival
0.6207041407	physical
0.6204633930	xanthomatosis
0.6203443349	imprinting
0.6203364638	phenotypic
0.6201481047	direct
0.6199585092	encoded
0.6196858846	canavan
0.6196004805	markers
0.6195047360	previously
0.6192923179	alterations
0.6191051068	carriers
0.6190365226	region
0.6189926828	implicated
0.6185419887	human chromosome
0.6185380589	strong
0.6185107951	state
0.6179565888	hemochromatosis
0.6175879266	factor
0.6174517579	amounts
0.6174517579	panel
0.6174173379	compound
0.6174053310	brain
0.6172674370	group
0.6170884745	fraction
0.6170884745	required
0.6170884745	leukodystrophy
0.6170884745	signs
0.6169207330	dna analysis
0.6165551012	human complement
0.6164168471	ratio
0.6163657411	order
0.6162808901	cancer susceptibility
0.6159810522	blood
0.6159427183	primary
0.6159046456	transcription
0.6158876327	familial cases
0.6157864335	diseases
0.6151615396	members
0.6148076980	gene expression
0.6143772208	variants
0.6143397789	previous
0.6139776788	prostate
0.6139750288	significant
0.6139623709	produce
0.6137505293	species
0.6133911105	sporadic
0.6131488691	bp
0.6128758134	rise
0.6127404999	risk
0.6126632753	transmission
0.6121669132	function
0.6118390891	differences
0.6115050921	percent
0.6114651100	low
0.6108193919	candidate
0.6107331091	deficiency
0.6106627555	genotype
0.6105993763	identified
0.6103661313	polyposis coli
0.6102281202	syndrome
0.6102194644	allele
0.6100948591	hemolytic
0.6098738509	locus
0.6098235219	kniest
0.6098026693	carry
0.6097622542	correlation
0.6095944575	cloning
0.6095162519	report
0.6093882087	enzyme
0.6093807660	incidence
0.6093685825	end
0.6092787637	stop
0.6090004165	chain
0.6087052040	long chain
0.6083867336	rate
0.6083562222	combination
0.6081527071	evaluation
0.6081243837	subjects
0.6080847701	results provide
0.6079864837	premature stop
0.6078548144	becker
0.6077134232	domains
0.6068922269	lupus
0.6067528829	zinc
0.6064563059	women
0.6063928777	lod
0.6063592050	deleted
0.6062661192	molecular basis
0.6061289507	binding
0.6059768236	cholesterol
0.6058356118	renal
0.6057707888	amplification
0.6048758447	disorder
0.6046797331	major
0.6046253799	trinucleotide
0.6046253799	comparison
0.6044203946	detected
0.6043370923	variable
0.6042510994	counseling
0.6041819484	cells
0.6037576039	substitutions
0.6034511499	restriction
0.6032177572	frequency
0.6027959828	characterized
0.6026313839	repeat length
0.6019377476	cetp deficiency
0.6017514907	mechanism
0.6015152817	activity
0.6014759438	increase
0.6014759438	maps
0.6014686264	structure
0.6013384702	cancer risk
0.6011405090	general
0.6011297318	serum
0.6009746711	screening
0.6009500163	groups
0.6009500163	therapy
0.6006829918	genotype phenotype
0.6006334728	animal
0.6004860694	congenital
0.6002618273	q13
0.6002451037	metabolism
0.6000857493	manifestations
0.6000498847	dystrophy
0.5998898617	association
0.5996250255	repeat expansion
0.5996227110	dystrophin
0.5995604391	15q11
0.5992870275	total
0.5989102381	repeat
0.5988723430	detect
0.5986542936	maximum
0.5984641050	gene product
0.5984307563	iron
0.5983945831	mps
0.5983435116	tumors
0.5979442831	thought
0.5979366762	reported
0.5979044794	cases
0.5977314130	specific
0.5976714830	characteristics
0.5976292045	identical
0.5973934765	site
0.5971436968	homologue
0.5970846014	sex
0.5970428868	breast
0.5969837945	carcinomas
0.5969750288	pathogenesis
0.5969151915	repeats
0.5968112439	lymphoproliferative
0.5968112439	percentage
0.5967388249	radiation
0.5967211168	liver
0.5964743238	involvement
0.5963714112	condition
0.5963013715	set
0.5963013715	assignment
0.5963013715	fluorescence
0.5962899932	skeletal
0.5962117214	consequence
0.5962117214	neurodegenerative
0.5961397119	observed
0.5958162177	isolation
0.5956000438	genes
0.5952448366	fibroblasts
0.5951319587	breast and ovarian cancers
0.5951057429	termination
0.5948905943	adult
0.5945853772	presented
0.5944597480	mapping
0.5940512041	age of onset
0.5938052545	critical
0.5937587098	vivo
0.5935982042	germline mutation
0.5935225195	deficient
0.5933567566	change
0.5932273603	form
0.5930123560	implications
0.5926679672	control
0.5922042645	abnormalities
0.5917772024	pendred
0.5917715986	north
0.5917631588	identification
0.5915305384	splice
0.5908163350	levels
0.5907845896	range
0.5906717595	terminal
0.5906075994	screened
0.5905824273	structural
0.5904493346	breast and ovarian
0.5903510537	present
0.5903152659	suggest
0.5902107445	heterozygotes
0.5901624129	identify
0.5899434242	estimated
0.5899183773	hypothesis
0.5897407516	half
0.5896159551	polymorphism
0.5892350723	addition
0.5891324194	homology
0.5889492885	defect
0.5885700211	revealed
0.5884541662	response
0.5883010493	closely
0.5879857073	unrelated
0.5879848453	characteristic
0.5876031564	localized
0.5875791180	pair
0.5873888715	member
0.5873888715	transgenic
0.5873277976	prevalence
0.5870760503	dystrophin gene
0.5870594686	sequencing
0.5866479187	phosphatase
0.5865836287	vision
0.5861739349	case
0.5861159898	death
0.5860104434	assay
0.5859214659	portion
0.5856398872	instability
0.5854152791	growth
0.5853466373	amino
0.5850036917	stem
0.5849693691	accumulation
0.5847217097	reading
0.5845302560	susceptibility gene
0.5845186431	intron
0.5843883764	messenger
0.5843281467	premature
0.5842590619	fragile
0.5842471182	analyzed
0.5836600370	recombinant
0.5831643331	alpha
0.5830511742	homologous
0.5824609461	effect
0.5819727091	proband
0.5819399999	carrier frequency
0.5818103422	peripheral
0.5816825661	onset
0.5816781801	forms
0.5810258929	conformation
0.5810099948	norrie
0.5809275167	heterogeneity
0.5807602657	southern blot analysis
0.5806988198	line
0.5804275465	prenatal
0.5804152926	carrier
0.5803342364	receptor
0.5803272308	damage
0.5803074837	expressed
0.5800911711	fap patients
0.5798535644	defined
0.5790111447	linked
0.5788772245	loss of heterozygosity
0.5783903770	domain
0.5783493939	kinase
0.5781539334	polymorphic
0.5780634807	frameshift
0.5780590377	loss
0.5780363836	dna binding
0.5772311185	late
0.5772311185	regulation
0.5771997814	model
0.5771515502	sporadic breast
0.5769563708	base pair deletion
0.5769211221	investigate
0.5764022591	mice carrying
0.5762331919	based
0.5757844598	dysplasia
0.5755855205	lack
0.5753192587	basis
0.5752354715	missense
0.5751967111	size
0.5747770516	in situ hybridization
0.5747339131	bp deletion
0.5746446136	cancers
0.5744808065	somatic mutations
0.5744334605	early
0.5741595385	pathway
0.5738984005	retinal
0.5738016232	tissue
0.5737027592	inheritance
0.5734168697	compared
0.5733958228	single nucleotide
0.5730202154	defects
0.5729629564	nonsense
0.5726879469	led
0.5725699418	breast ovarian cancer families
0.5723564036	germline mutations
0.5721524919	base
0.5719994338	close
0.5716780562	confirmed
0.5714960846	anemia
0.5714877402	polymorphisms
0.5711986583	compatible
0.5708638109	occurred
0.5707660890	brca1 or brca2
0.5705187138	acid
0.5705011012	findings
0.5704912326	features
0.5697880345	provide
0.5697184802	vwf
0.5696976125	localization
0.5696965883	interval
0.5691898245	theta
0.5688223736	population based
0.5684468453	distribution
0.5681206545	recessive
0.5679022715	related
0.5677352397	component
0.5677284965	hepatic
0.5677111932	involved
0.5676876206	carcinoma
0.5676853250	acyl
0.5676853250	finger
0.5674800540	kb
0.5671650531	phenylalanine
0.5668516410	glucose
0.5667118011	possibility
0.5663767177	development
0.5659997021	demonstrate
0.5652520622	potential
0.5649976070	encodes
0.5648007510	substitution
0.5643804536	male breast cancer
0.5639409121	carrying
0.5638625883	amino acid substitution
0.5638478876	disorders
0.5638304038	autosomal
0.5637528411	symptoms
0.5632249935	beta
0.5629760625	effects
0.5628177378	shown
0.5619199358	susceptibility
0.5617984420	lines
0.5613160769	negative
0.5610257108	coding
0.5609305156	inactivation
0.5608679562	chinese
0.5606152254	caused
0.5602940723	cos
0.5601272791	ovarian
0.5600737342	gel
0.5597618949	polymorphic markers
0.5594739527	determined
0.5594194500	candidate gene
0.5593343700	correlations
0.5592129807	hybridization
0.5589157663	fragment
0.5589139363	cpg
0.5589038781	transcript
0.5587649876	normal
0.5587051643	map
0.5584897906	dcc
0.5584664663	density
0.5579413700	length
0.5578755437	decreased
0.5578385531	transport
0.5578385531	elevated
0.5577177389	membrane
0.5576117447	multiple
0.5575131771	transition
0.5574210160	contribute
0.5572834389	xq28
0.5571967564	severity
0.5570595352	encoding
0.5568403179	cd
0.5565680119	expansion
0.5563818438	nuclear
0.5562227144	ews
0.5557270026	obtained
0.5556658192	product
0.5556487075	pcr products
0.5556053867	expanded
0.5552175427	located
0.5551737870	proximal
0.5551666241	detection
0.5545999939	alu
0.5544145561	resulted
0.5543813866	hmgic
0.5542499693	polyposis
0.5542298381	pten
0.5541838829	dehydrogenase
0.5541015690	derived
0.5536026458	highly
0.5534098672	fmr1
0.5533555494	tp53
0.5532577728	males
0.5531369642	splice site mutation
0.5528923098	dna markers
0.5528257487	int14
0.5527798111	msh2
0.5527798111	d2
0.5526044050	stage
0.5526044050	lesions
0.5522958122	ec
0.5522958122	atp
0.5521103449	conclusions
0.5520516782	position
0.5520242161	progressive
0.5516008655	spondylitis
0.5515427093	result
0.5514486584	date
0.5510670569	occur
0.5510417625	dependent
0.5508550531	history
0.5507853667	finally
0.5507597462	gaa
0.5507224519	appears
0.5507060854	sp1
0.5506180473	subunit
0.5505761900	resulting
0.5504668270	regions
0.5502323546	point
0.5499644830	ability
0.5499508021	b27
0.5495930056	la
0.5495838562	six5
0.5495072018	mapped
0.5490871729	thr
0.5489595960	mutant alleles
0.5488743844	dtdst
0.5484110726	atp7b
0.5482764168	arg
0.5481774326	donor
0.5481255051	mb
0.5480957780	arm
0.5479717479	fluorescence in situ
0.5479552547	contrast
0.5478904626	tumour
0.5478891206	xp21
0.5475804629	strand
0.5473939025	sglt1
0.5473939025	n314d
0.5472439620	translocation
0.5472211742	gly
0.5470147608	finnish
0.5469395710	n370s
0.5469395710	genet
0.5469395710	c4
0.5468764842	central
0.5467488674	single base
0.5467213629	tcd
0.5464865306	rare
0.5461333106	aspa
0.5459687008	level
0.5458696900	npii
0.5458696900	ao
0.5458215567	relative
0.5455901211	mri
0.5455368849	types
0.5454915304	dgs
0.5454915304	sjs
0.5454506270	distal
0.5453849709	pdgfb
0.5449970759	ocrl
0.5449547190	untranslated
0.5447036985	mhc
0.5447036985	hms
0.5446436618	ube3a
0.5446436618	xlrs1
0.5446155775	occurrence
0.5440667858	test
0.5439971830	agu
0.5439469014	kit
0.5434034622	score
0.5431155775	proportion
0.5430532553	sls
0.5426976680	age at diagnosis
0.5426897575	formation
0.5425707572	pls
0.5423876090	snrpn
0.5423733505	japan
0.5423733505	l1
0.5423733505	sit
0.5423423031	dxs7
0.5418912573	humans
0.5417558364	protein truncation
0.5417312998	long arm of chromosome
0.5417178111	diabetes
0.5417017337	magel2
0.5415005622	apoc2
0.5415005622	sca3
0.5410392477	rflp
0.5409924219	ataxia
0.5408681290	aj
0.5408564553	objective
0.5407632263	cug
0.5404558373	disequilibrium
0.5403463383	an2
0.5403463383	s135l
0.5400383235	hh
0.5398074302	yac
0.5396590742	allele specific
0.5396071139	nbs
0.5395420753	responsible
0.5390978275	dtd
0.5390390593	alps
0.5388522228	cp
0.5388260850	met
0.5387260067	i1307k
0.5387074081	mefv
0.5385794709	bmd
0.5385192510	gd
0.5382230252	gs
0.5382230252	aapc
0.5381851452	pmd
0.5380412176	number
0.5379765335	mjd
0.5379591153	edmd
0.5378587496	phosphate
0.5376392230	leads
0.5374410060	consistent
0.5373920857	absence
0.5373332213	causing
0.5370020870	h63d
0.5367210569	dmt1
0.5363275625	gt
0.5362826179	avp
0.5362695586	p16ink4a
0.5362194792	disease causing
0.5361417726	role
0.5360500872	c6 deficiency
0.5358602842	hgo
0.5357807211	gldc
0.5355543387	fmrp
0.5354427383	fas
0.5354107473	ricof
0.5353562154	predicted
0.5353317097	frame
0.5350632086	protein product
0.5350542025	fmf
0.5349869499	chm
0.5347000931	apoe
0.5346809215	cancer susceptibility gene
0.5344941582	central nervous system
0.5344891457	amn
0.5342848839	tf
0.5341577557	d442g
0.5336488321	tfr
0.5332866625	rflps
0.5332250279	arsa
0.5331307717	rcc
0.5330990264	galns
0.5330891457	mld
0.5329982632	iq
0.5329514365	leu
0.5328603536	hydroxylase
0.5328338189	dds
0.5326403026	suppressor
0.5325942822	interestingly
0.5322684773	lead
0.5321968818	val
0.5320862977	muscular
0.5319930676	degree
0.5314909076	germ
0.5310660068	loh
0.5309615428	mental
0.5308744537	enzyme deficiency
0.5306693342	haplotype analysis
0.5306282095	retardation
0.5304382362	conserved
0.5301771954	caucasians
0.5299714647	determine
0.5298767017	piebaldism
0.5296008235	bard1
0.5295552764	ctx
0.5292096790	duarte
0.5291877183	galt
0.5288127217	fish
0.5287735832	characterization
0.5287663034	col17a1
0.5287663034	cdk4
0.5285773532	alkaptonuria
0.5285642680	pattern
0.5283081708	mutated
0.5280522133	account
0.5274564054	q188r
0.5267186910	yeast
0.5266832367	vws
0.5266656244	wild
0.5265966291	aga
0.5265638463	huntington
0.5264103885	colorectal tumors
0.5258995463	erg
0.5256443853	coli
0.5254371363	situ
0.5253905625	frda
0.5253580778	restriction fragment
0.5252168964	reaction
0.5247335034	tsd
0.5246443853	leading
0.5243099841	c2q0
0.5240350087	cdh1
0.5239116031	ptt
0.5238130757	dmpk
0.5237721053	colchicine
0.5237721053	overexpression
0.5236264655	multipoint
0.5234169695	proteins
0.5234110493	blot
0.5231003114	anticipation
0.5230865891	conclusion
0.5229622407	mouse chromosome
0.5226045807	glu
0.5222770715	targeted
0.5220298031	hfe
0.5219046746	fourth
0.5219046746	knowledge
0.5217440653	fatty
0.5212545156	pku
0.5211619827	sf
0.5205258220	copper
0.5204982327	rds
0.5204913550	acids
0.5204465184	hp2
0.5202106824	meiotic
0.5196755929	frataxin
0.5194950352	marker
0.5194398626	mutant mice
0.5193839911	ph
0.5191763012	black
0.5189635589	subsequent
0.5187358133	aberrant
0.5185396052	critical region
0.5180775623	submicroscopic
0.5180775623	investigation
0.5180775623	sera
0.5180775623	stable
0.5180775623	subsequently
0.5180775623	diverse
0.5180129695	deficient mice
0.5177298288	very long chain fatty
0.5176345284	cis
0.5171255715	deficiencies
0.5168571571	cytogenetic
0.5168571571	constitutional
0.5161882643	apolipoprotein
0.5161610730	iii
0.5161037410	men
0.5159675486	extracts
0.5159675486	erythrocyte
0.5159675486	considerable
0.5159675486	hemizygous
0.5156467775	rearrangement
0.5154278408	obesity
0.5154278408	embryos
0.5154278408	transversion
0.5154278408	brother
0.5154278408	asymptomatic
0.5154278408	copy
0.5154278408	anti
0.5154278408	excess
0.5153988082	pendrin
0.5149874335	c5
0.5147010775	electrophoretic
0.5146117906	extensive
0.5144574271	choroideremia
0.5140974833	fatal
0.5140974833	moderate
0.5140974833	lymphocyte
0.5140974833	conservation
0.5137497488	pws
0.5134714349	information
0.5132391369	obligate
0.5132391369	marked
0.5132391369	patterns
0.5132391369	classic
0.5131862700	quantitative
0.5129757621	milder
0.5129315065	cyp27
0.5128918655	chain acyl coa
0.5128213411	q21
0.5123325795	genetically
0.5122707009	current
0.5120026967	residual
0.5120026967	pedigree
0.5120026967	markedly
0.5117185132	specifically
0.5117185132	variability
0.5115654915	ala
0.5114017965	affected males
0.5110404542	detailed
0.5102876646	hmre11
0.5095622370	nbs1
0.5093250832	anterior
0.5093250832	increasing
0.5092525845	absent
0.5092525845	benign
0.5092525845	adrenomyeloneuropathy
0.5090623225	ocular
0.5089144142	meioses
0.5089144142	vector
0.5089144142	polyglutamine
0.5089144142	transmitted
0.5089144142	shared
0.5089144142	boys
0.5089144142	isoform
0.5089144142	surface
0.5089144142	inhibitor
0.5086692218	brca1 mutations
0.5082986269	extended
0.5082986269	cleavage
0.5082986269	initial
0.5079387763	combined
0.5078593636	criteria
0.5078593636	program
0.5078593636	predominant
0.5078593636	interstitial
0.5078593636	intact
0.5078593636	causative
0.5078593636	environmental
0.5077226414	nm23
0.5077226414	glycoprotein
0.5076495018	reported previously
0.5075879502	huntingtin
0.5075879502	considered
0.5075197417	origins
0.5075197417	initiation
0.5075197417	precursor
0.5075197417	paired
0.5072046418	oligonucleotide
0.5072046418	phosphoribosyltransferase
0.5072046418	extremely
0.5072046418	generate
0.5072046418	recognition
0.5072046418	refs
0.5072046418	clone
0.5072046418	glutamine
0.5072046418	noted
0.5072046418	sensitivity
0.5072046418	production
0.5072046418	p95
0.5072046418	overlapping
0.5072046418	newly
0.5072046418	disrupted
0.5072046418	importance
0.5072046418	explanation
0.5072046418	triplet
0.5072046418	distributed
0.5072046418	target
0.5072046418	encode
0.5072046418	restricted
0.5072046418	confirm
0.5072046418	bands
0.5072046418	artificial
0.5072046418	homeostasis
0.5072046418	molecule
0.5072046418	widely
0.5072046418	regulate
0.5072046418	irradiation
0.5072046418	involves
0.5072046418	times
0.5072046418	processing
0.5072046418	22q11
0.5072046418	pre
0.5069131717	introns
0.5069131717	erythrocytes
0.5069131717	arylsulfatase
0.5069131717	lies
0.5069131717	elements
0.5069131717	insertions
0.5069131717	procedure
0.5069131717	tool
0.5069131717	girl
0.5069131717	evaluated
0.5069131717	spliced
0.5069131717	concentration
0.5069131717	possibly
0.5069131717	predominantly
0.5069131717	interaction
0.5069131717	originated
0.5069131717	simple
0.5069131717	provided
0.5069131717	polypeptide
0.5069131717	localize
0.5069131717	reveals
0.5069131717	arise
0.5069131717	evident
0.5069131717	average
0.5068620299	duplications
0.5064955087	aku
0.5064924650	theta = 0
0.5060150675	twins
0.5060034600	difference
0.5057846536	measured
0.5057846536	stimulation
0.5056115264	mothers
0.5052765203	apparent
0.5052610974	sscp analysis
0.5050196162	platelets
0.5048842596	oncogene
0.5046090827	muscles
0.5046090827	chimeric
0.5046090827	mammalian
0.5044906603	class
0.5041711391	resolution
0.5041711391	juvenile
0.5041711391	decrease
0.5041711391	comprehensive
0.5041711391	transient
0.5041711391	complexes
0.5041711391	endogenous
0.5038533369	fragments
0.5038527645	twin
0.5036128475	retained
0.5036128475	syndromic
0.5030604436	proliferation
0.5030604436	purified
0.5028738087	somatic mutation
0.5028609809	rapid
0.5028286544	parent
0.5027133084	qter
0.5027133084	consanguineous
0.5027133084	pathways
0.5025371680	surrounding
0.5025371680	adjacent
0.5025371680	step
0.5025371680	share
0.5025371680	homolog
0.5025371680	remained
0.5025371680	separate
0.5025371680	hybrid
0.5025371680	translocations
0.5025371680	assessed
0.5025371680	assigned
0.5025371680	manner
0.5025371680	conditions
0.5025371680	ancestry
0.5025371680	exclusively
0.5025371680	predispose
0.5025371680	hexosaminidase
0.5022144586	ml
0.5022144586	chemotactic
0.5019827579	activation
0.5016017057	expansions
0.5016003686	lie
0.5016003686	search
0.5016003686	parts
0.5016003686	place
0.5016003686	producing
0.5016003686	elucidate
0.5016003686	examine
0.5016003686	crucial
0.5016003686	experiments
0.5016003686	transfected
0.5016003686	presumed
0.5016003686	insight
0.5016003686	highest
0.5016003686	differ
0.5016003686	characterised
0.5016003686	calculated
0.5016003686	strains
0.5016003686	migration
0.5016003686	sulfatase
0.5016003686	degrees
0.5016003686	gain
0.5016003686	lesion
0.5016003686	locations
0.5016003686	free
0.5016003686	predisposing
0.5016003686	4p16
0.5016003686	primers
0.5016003686	processed
0.5016003686	living
0.5016003686	transmitting
0.5016003686	transgene
0.5016003686	antigen
0.5016003686	copies
0.5016003686	digestion
0.5016003686	coupled
0.5016003686	staining
0.5016003686	threonine
0.5016003686	proline
0.5016003686	inhibited
0.5016003686	interacts
0.5016003686	comprising
0.5016003686	rapidly
0.5016003686	demonstrating
0.5016003686	reduce
0.5016003686	represented
0.5016003686	obvious
0.5016003686	woman
0.5015803336	intronic
0.5014634667	systems
0.5013739125	germ line mutations
0.5012504875	tests
0.5007649028	background
0.5005433703	outcome
0.5004271445	age at onset
0.5001360348	spot
0.4998715113	predicts
0.4998715113	minimal
0.4998715113	estimate
0.4998715113	laboratory
0.4998715113	ascertained
0.4998715113	regulated
0.4998715113	published
0.4998715113	hot
0.4998715113	geographic
0.4998715113	confirms
0.4998715113	restored
0.4998715113	understood
0.4998715113	techniques
0.4998715113	introduced
0.4998715113	consists
0.4998715113	view
0.4998715113	tandem
0.4998715113	boundaries
0.4998715113	unilateral
0.4998715113	characterize
0.4998715113	cataract
0.4998715113	segments
0.4998715113	span
0.4998715113	residues
0.4998715113	secretion
0.4998715113	affects
0.4998715113	correlate
0.4998715113	overlap
0.4998715113	therapeutic
0.4998715113	excluded
0.4998715113	interact
0.4998715113	interactions
0.4998715113	fetus
0.4998715113	bind
0.4998715113	checkpoint
0.4998715113	conducted
0.4998715113	independently
0.4998715113	dominantly
0.4998715113	remain
0.4998715113	fold
0.4998715113	link
0.4998715113	secondary
0.4998715113	follow
0.4998715113	reports
0.4994993577	unstable
0.4994993577	glycine
0.4994993577	stability
0.4994993577	genotypes
0.4994993577	represents
0.4994993577	upstream
0.4994993577	isoforms
0.4994993577	completely
0.4994993577	includes
0.4994993577	remains
0.4994993577	leukocytes
0.4994811577	185delag
0.4994811577	sister
0.4994484850	constructed
0.4994484850	rich
0.4994484850	cdnas
0.4994484850	ancestral
0.4994484850	paternally
0.4994484850	nucleotides
0.4994484850	analysed
0.4992369901	lymphoproliferative syndrome
0.4988650071	unusual
0.4988650071	cataracts
0.4988650071	bilateral
0.4988650071	pathological
0.4988650071	propose
0.4988650071	offspring
0.4988650071	mature
0.4988650071	increases
0.4988650071	produces
0.4988650071	tumorigenesis
0.4988650071	clear
0.4988650071	generation
0.4988191336	mutational
0.4986495366	apoptosis
0.4986363531	sibs
0.4986363531	meningitis
0.4983656183	animals
0.4983032659	smaller
0.4982624810	ref
0.4982053547	deafness
0.4981761380	functional
0.4980947092	assays
0.4980642728	mutants
0.4979827688	secreted
0.4979827688	similarity
0.4979827688	arose
0.4979827688	neurons
0.4979827688	treated
0.4979827688	express
0.4979827688	cryptic
0.4979827688	significance
0.4972334830	apoa
0.4970419416	birth
0.4970419416	imprinted
0.4962671481	ataxin 3
0.4962501209	tumour suppressor gene
0.4961678794	typical
0.4961678794	independent
0.4958882686	apparently
0.4957855892	functions
0.4957329014	genetic defect
0.4955814477	cosmid
0.4955814477	intermediate
0.4955814477	bases
0.4955814477	developing
0.4955814477	foci
0.4955494570	kilobases
0.4951896999	del
0.4946756027	recent
0.4946651371	clinical phenotype
0.4945972280	intergenerational
0.4945972280	persons
0.4945972280	extent
0.4945972280	p53
0.4945972280	regulatory
0.4945972280	transcribed
0.4945972280	serine
0.4945972280	spanning
0.4945972280	alteration
0.4945972280	downstream
0.4945972280	exhibited
0.4945972280	intracellular
0.4945720830	brothers
0.4943095353	h
0.4937233503	activities
0.4935245850	dna samples
0.4933041005	k
0.4932227753	partial
0.4931091146	cm
0.4930642743	null
0.4928744331	thrombocytopenia
0.4927772926	pedigrees
0.4926805024	partially
0.4926805024	include
0.4926805024	translation
0.4926805024	limited
0.4926805024	heterogeneous
0.4925331120	intragenic
0.4925331120	promoter
0.4925331120	father
0.4917498000	mdx
0.4917498000	mobility
0.4917498000	identity
0.4917498000	uptake
0.4917498000	typing
0.4915463459	collagen
0.4915380319	maximum lod
0.4911420450	descent
0.4908423300	sperm
0.4908393498	healthy
0.4907655803	severely
0.4907655803	preferentially
0.4907655803	lipoproteins
0.4907655803	trait
0.4907655803	dietary
0.4905024290	first degree relatives
0.4904373517	truncated
0.4903874048	phenylketonuria
0.4902147323	apob
0.4897977329	designated
0.4897977329	abnormality
0.4897977329	established
0.4897977329	skipping
0.4896329774	females
0.4894950377	11p13
0.4894624860	undetectable
0.4890423688	allelic
0.4886752200	kda
0.4877097993	selective
0.4873206644	components
0.4873206644	supports
0.4873206644	play
0.4873206644	observation
0.4873206644	directly
0.4873206644	subject
0.4873206644	rates
0.4873206644	contained
0.4873206644	affect
0.4872196457	functionally
0.4869625009	cultured
0.4857052903	homozygotes
0.4857052903	called
0.4856939813	segregating
0.4856939813	technique
0.4856939813	exhibit
0.4856939813	included
0.4856939813	developmental
0.4856939813	approach
0.4856939813	breakpoint
0.4851830135	informative
0.4851830135	models
0.4851830135	residue
0.4851830135	unaffected
0.4851830135	sufficient
0.4851830135	mosaicism
0.4851830135	proposed
0.4851794789	strongly
0.4851794789	band
0.4851794789	selected
0.4851794789	showing
0.4851794789	frequencies
0.4851560750	expressing
0.4851560750	breakpoints
0.4848296750	prevalent
0.4848296750	sample
0.4848296750	facilitate
0.4848296750	represent
0.4848296750	recognized
0.4848296750	explain
0.4848296750	produced
0.4848296750	concentrations
0.4837950958	months
0.4835596934	classical
0.4833918304	clinically
0.4826313917	rather
0.4826312541	galactosemia
0.4823942660	risk of breast cancer
0.4820030741	low levels
0.4813452529	none
0.4813201045	cellular
0.4808848233	the present study
0.4803378393	findings suggest
0.4802857462	altered
0.4800528587	codons
0.4800528587	finding
0.4798861920	develop
0.4796627305	methods
0.4789671519	transferrin
0.4787693399	generated
0.4787693399	lower
0.4787693399	underlying
0.4785764213	kindred
0.4785764213	generations
0.4784861920	siblings
0.4784861920	expected
0.4784861920	conclude
0.4784861920	event
0.4784861920	transcriptional
0.4782855817	arginine
0.4782855817	shows
0.4777102882	segment
0.4777102882	affecting
0.4775243446	autosomal recessive disorder
0.4759695957	mechanisms
0.4753789415	linked recessive
0.4752711388	mutation analysis
0.4747119136	results suggest
0.4746596327	childhood
0.4736202522	aniridia
0.4733028484	parents
0.4731843360	unknown
0.4730600177	exons
0.4729870137	positive
0.4729870137	clones
0.4725961230	rearrangements
0.4724559682	recently
0.4718569246	defective
0.4711332872	few
0.4708831986	factors
0.4708526100	recurrent
0.4706475219	rat
0.4706475219	mother
0.4705413407	probe
0.4705413407	frequently
0.4703492433	transcripts
0.4701558552	remaining
0.4701558552	tested
0.4701558552	murine
0.4701558552	carried
0.4695735329	plasma
0.4695264503	penetrance
0.4693449560	complete
0.4693393297	higher
0.4692865099	last
0.4683565105	putative
0.4678121014	far
0.4672640468	so
0.4668068388	involving
0.4667147756	paternal
0.4659922445	events
0.4659922445	indicating
0.4659922445	unique
0.4659922445	investigated
0.4659854102	sequenced
0.4659598453	deletions
0.4658804098	treatment
0.4656580593	maternal
0.4655133570	tumours
0.4651253448	amplified
0.4649255316	variant
0.4647203869	l
0.4645760933	probes
0.4645760933	diagnosed
0.4645760933	detectable
0.4643423227	emerin
0.4642990723	occurs
0.4640069958	method
0.4639622199	additional
0.4637398143	retinoblastoma
0.4636969016	z
0.4635514705	binding protein
0.4635300808	analyses
0.4635273081	small
0.4627759309	biochemical
0.4625550141	c
0.4619476982	example
0.4611607621	blood cells
0.4605249042	mediated
0.4605249042	flanking
0.4605249042	suggested
0.4603201474	chromosomes
0.4593386929	reduced
0.4592024011	the c282y mutation
0.4586051848	sequences
0.4582627771	kindreds
0.4577798023	abnormal
0.4569092061	results demonstrate
0.4567370764	p
0.4565446498	cathepsin c
0.4564949931	lymphocytes
0.4556909407	mild
0.4550677744	approximately
0.4544082116	to
0.4536791531	children
0.4532229836	on
0.4530231356	mrna
0.4520376288	by
0.4519329739	data suggest
0.4513699998	t
0.4508496457	donor splice
0.4499725639	at
0.4499620422	induced
0.4483135181	the hexa gene
0.4476549535	de novo
0.4470543660	significantly
0.4470322278	together
0.4468350796	this
0.4467032458	including
0.4462432382	here
0.4457120826	the pds gene
0.4457032458	cdna
0.4453519146	individual
0.4451400183	cloned
0.4450543660	support
0.4448613340	showed
0.4448277503	x
0.4447776251	japanese patients
0.4446614384	probands
0.4441801659	insertion
0.4441472722	developed
0.4440335191	95 confidence interval
0.4439397792	these
0.4439116252	g
0.4437680993	novel
0.4436118580	previous studies
0.4430845984	likely
0.4425125994	s
0.4422698255	new
0.4422123497	in
0.4407764621	ca2 +
0.4399998370	old
0.4384860050	most
0.4383630571	recessive disorder
0.4375917975	years
0.4373415411	important
0.4373261121	studied
0.4370863265	et al
0.4368415411	distinct
0.4368415411	performed
0.4364373859	whether
0.4364156898	suggests
0.4363437350	an
0.4363261121	demonstrated
0.4362834570	for
0.4360692647	n
0.4357447119	unrelated patients
0.4353261121	origin
0.4350599061	found
0.4342407767	full
0.4340437201	b
0.4326317036	loci
0.4322190904	as
0.4312370679	phenotypes
0.4311796865	mutations causing
0.4308532913	wasp gene
0.4306828510	sites
0.4306305528	tissues
0.4303751587	haplotypes
0.4303751587	populations
0.4301493106	controls
0.4293417660	one
0.4285611908	suggesting
0.4271497759	female
0.4266976480	more
0.4261816955	family history
0.4261497759	examined
0.4247580832	the
0.4246796719	polymorphism analysis
0.4237945921	a
0.4225616223	first
0.4224751071	nervous system
0.4223823264	data provide
0.4216933931	corresponding
0.4214681080	less
0.4206481212	from
0.4206295505	wt1 gene
0.4199843852	de
0.4191694275	such
0.4190016793	three
0.4186959165	hydroxylase gene
0.4184119336	no
0.4181729768	not
0.4174674192	only
0.4172800940	like
0.4171856958	phenotypic expression
0.4168017419	recessive disorder characterized by
0.4151883204	of
0.4148684794	seen
0.4144353984	with
0.4142354551	associated
0.4131564739	appear
0.4120286919	95
0.4108869013	also
0.4098441834	use
0.4094248559	mutant allele
0.4082517867	but
0.4070235052	apc mutations
0.4065140136	all
0.4063740419	0
0.4041740906	glucose 6 phosphate
0.4040539948	well
0.4040028622	+
0.4036841493	6
0.4034284620	complex
0.4027196417	within
0.4022949240	different
0.4010249703	year
0.3997801611	non
0.3987238438	do
0.3979716734	x linked adrenoleukodystrophy
0.3974522925	than
0.3968306122	changes
0.3966156049	3
0.3963665956	does
0.3963226609	the wiskott aldrich
0.3960093833	very
0.3959422394	followed
0.3949823009	=
0.3942821467	1
0.3934126161	between
0.3923489383	5
0.3917208593	4
0.3908682099	the long arm
0.3900256277	did
0.3894831674	described
0.3890789984	untranslated region
0.3884644751	used
0.3874421239	two
0.3865016433	or
0.3855657038	x linked
0.3854126546	cause
0.3839434457	part
0.3839400267	due
0.3838048736	other
0.3833072692	9
0.3832877238	7
0.3829184260	14
0.3824751566	11
0.3822432235	same
0.3820002064	2
0.3783258081	8
0.3778213976	increased risk
0.3777205773	further
0.3768859241	13
0.3748312429	15
0.3734933192	nd
0.3734626420	12
0.3715595778	known
0.3712674069	indicate
0.3696816544	20
0.3683880271	system
0.3680031434	j
0.3676104066	f
0.3637394853	donor site of
0.3623618415	m
0.3510626665	renal cell
0.3488488409	general population
0.3483205987	the entire coding region
0.3464576305	r
0.3448492504	and
0.3446122617	moreover
0.3425678055	y
0.3425628086	the mjd1 gene
0.3379903767	year old
0.3377411036	i
0.3376291491	d
0.3325880606	fragment length
0.3311596721	full length
0.3308489494	twenty
0.3294851311	she
0.3293990240	given
0.3292200685	furthermore
0.3284959141	x linked recessive
0.3268825901	despite
0.3265210517	neither
0.3262029235	ten
0.3262029235	twelve
0.3262002442	brca1 mutation
0.3258607165	e
0.3257383076	long arm of
0.3233071216	85
0.3233071216	76
0.3227900007	non jewish
0.3227816792	co
0.3225070325	38
0.3218838392	799
0.3211785198	dehydrogenase deficiency
0.3205120506	72
0.3195113639	these results suggest
0.3194347830	whole
0.3190600137	he
0.3181629480	atm protein
0.3180383726	71
0.3173985914	under
0.3173985914	nearly
0.3173985914	latter
0.3173985914	82
0.3173985914	hundred
0.3173985914	86
0.3168709771	though
0.3164368024	66
0.3164368024	61
0.3163793585	give
0.3159929864	loss of function
0.3155687197	200
0.3154826996	52
0.3154826996	57
0.3150606986	overall
0.3148384240	clearly
0.3148384240	75
0.3148384240	63
0.3147980522	along
0.3147980522	little
0.3143913228	certain
0.3136605329	94
0.3136270204	then
0.3126396983	04
0.3126396983	alone
0.3118975266	around
0.3118975266	always
0.3118975266	03
0.3118975266	especially
0.3118975266	course
0.3118975266	84
0.3112062220	necessary
0.3112062220	01
0.3110080886	62
0.3107187740	97
0.3107187740	49
0.3107187740	47
0.3107187740	people
0.3107187740	250
0.3107187740	41
0.3107187740	amount
0.3107187740	65
0.3107187740	inner
0.3107187740	must
0.3107187740	allow
0.3104561486	we
0.3103055516	however
0.3101014326	00
0.3098449059	fragile x
0.3094144020	mean
0.3093185327	43
0.3092833445	10
0.3092283511	thus
0.3083534491	37
0.3079684219	46
0.3075039927	his
0.3074882578	although
0.3070979678	mutation in exon
0.3068625940	68
0.3066908957	55
0.3066782894	near
0.3066782894	even
0.3061622875	chromosome region
0.3058803524	still
0.3058803524	150
0.3058803524	usually
0.3058803524	300
0.3057133119	upon
0.3054702421	since
0.3046132565	locus on chromosome
0.3045447952	available
0.3023811078	our
0.3023024269	if
0.3021503300	35
0.3021503300	26
0.3021415966	accounted for
0.3020178922	it
0.3018040122	fifth
0.3018040122	made
0.3018040122	39
0.3018040122	33
0.3015273804	99
0.3015097765	cannot
0.3015097765	others
0.3014234673	was
0.3011496891	where
0.3007524223	31
0.3006030102	05
0.3005595194	51
0.3004886740	s phase
0.3001980103	us
0.2999363549	site of intron
0.2990786692	001
0.2987877218	per
0.2985661998	failed to
0.2973413536	100
0.2973413536	45
0.2970622801	nine
0.2970461599	their
0.2968864414	her
0.2968291277	23
0.2961468710	almost
0.2960639833	they
0.2959865611	using
0.2957972270	four
0.2956669712	second
0.2956246950	following
0.2953512090	90
0.2952732637	over
0.2951609480	40
0.2951494364	third
0.2946746869	48
0.2945538858	contain
0.2943066609	both
0.2942098168	another
0.2941520532	out
0.2941118568	36
0.2940055542	expanded allele
0.2937398016	28
0.2934364004	24
0.2934364004	32
0.2934364004	particularly
0.2934364004	useful
0.2931644830	44
0.2930881252	60
0.2930526275	an autosomal recessive
0.2927587180	indicates
0.2927369348	80
0.2927369348	25
0.2927165065	there
0.2925805137	often
0.2925805137	mainly
0.2924747902	while
0.2924539407	normally
0.2924539407	throughout
0.2922664407	value
0.2921044473	before
0.2919883076	six
0.2919733268	among
0.2919503009	yet
0.2918244117	whose
0.2918244117	70
0.2918244117	later
0.2912496385	5 phosphatase
0.2911113039	because
0.2909194443	hprt gene
0.2909190756	would
0.2904872000	34
0.2904872000	much
0.2904872000	whom
0.2904872000	nor
0.2902751277	five
0.2900123677	22
0.2890361772	27
0.2885826488	therefore
0.2885160453	particular
0.2879941924	arm of chromosome
0.2871055881	18
0.2871028384	seven
0.2870593538	many
0.2866601154	19
0.2863335207	them
0.2861208376	being
0.2857875042	relatively
0.2854251996	various
0.2853382240	indicated
0.2853382240	probably
0.2853382240	up
0.2853205607	its
0.2847104352	000
0.2842084975	provides
0.2839039241	29
0.2838507689	region of chromosome
0.2836590156	when
0.2835001642	21
0.2833374350	each
0.2831051251	some
0.2829338197	who
0.2827117162	95 confidence
0.2826942223	been
0.2822037584	are
0.2821787584	be
0.2821787584	is
0.2821787584	were
0.2821787584	that
0.2821787584	have
0.2820188372	about
0.2817692531	after
0.2813644323	might
0.2811787584	which
0.2804234355	describe
0.2803374350	several
0.2799014994	time
0.2794287356	contains
0.2794287356	having
0.2793993244	had
0.2791993244	has
0.2784883705	against
0.2781993244	may
0.2781978246	eight
0.2780597991	now
0.2778850696	inherited breast
0.2748068946	17
0.2741881146	30
0.2739193288	show
0.2737609697	possible
0.2727112202	16
0.2724391989	whereas
0.2719193288	can
0.2715880177	those
0.2709177739	50
0.2697196983	normal human
0.2696818356	exon 11
0.2684705299	through
0.2684285082	during
0.2673049361	could
0.2655234235	will
0.2644718741	na +
0.2643049361	into
0.2621420427	should
0.2611653257	containing
0.2605659773	responsible for
0.2602180468	respectively
0.2598071640	n terminal
0.2593120832	any
0.2591653257	either
0.2590578663	without
0.2585971921	causes
0.2562657600	chromosome 14
0.2542059534	by polymerase chain reaction
0.2524798569	determine whether
0.2514634004	gene encodes
0.2493417772	factor b
0.2440722801	does not
0.2439166737	caused by
0.2431986281	x chromosome
0.2430651488	z =
0.2429982858	disease gene
0.2425435250	germ line mutations in
0.2419695669	at least
0.2398082541	the entire coding
0.2391978142	an autosomal recessive disorder
0.2358653913	the pathogenesis of
0.2343697959	p =
0.2341633854	disease locus
0.2328980077	as well as
0.2283251086	the seventh
0.2273700469	previously described
0.2272050178	the wiskott aldrich syndrome
0.2269397788	n =
0.2262645578	x ald
0.2255580450	so far
0.2237946487	p 0
0.2223322425	gene deletion
0.2207107369	c to t
0.2199473367	the nucleus
0.2194798188	the entire
0.2177962983	suppressor gene
0.2175046801	rb1 gene
0.2173581337	disorder caused by
0.2162695548	exon 13
0.2159230061	greater than
0.2148334281	closely linked to
0.2144478167	these findings suggest
0.2144273121	the results of
0.2134487660	did not
0.2104126558	rather than
0.2095973367	the world
0.2093412499	a stop codon
0.2091428514	existence of
0.2091105965	the brca1 gene
0.2087569813	gene encoding
0.2057498354	a panel of
0.2044708055	the apc gene
0.2023133480	cancer cases
0.2023065122	japanese patients with
0.2009227022	3 utr
0.2008138394	exon 6
0.2006494307	pax6 gene
0.1995286454	account for
0.1992365068	consistent with
0.1986278520	leading to
0.1985667849	disorder characterized by
0.1984597262	do not
0.1976089194	t transition
0.1973635979	subset of
0.1970238932	male patients
0.1939129264	results indicate
0.1938652983	first degree
0.1924878341	chromosome 15
0.1920470178	an autosomal dominant
0.1912866166	these data suggest
0.1902447196	heterogeneity of g6pd
0.1892417085	variety of
0.1883743492	exon 7
0.1876333390	apc gene
0.1871202487	presence of
0.1867036946	based on
0.1863202047	exon 9
0.1861691254	majority of
0.1855499115	germline mutations in
0.1846795405	candidate gene for
0.1841862867	lod score of
0.1837746622	the general population
0.1833636687	3 untranslated region
0.1804330355	correlation between
0.1801698985	due to
0.1799046678	the presence
0.1796888337	able to
0.1795969538	the most common
0.1791423967	family history of
0.1785290385	the existence
0.1784634374	sequence analysis of
0.1781825364	exon 8
0.1779130484	nonsense mutation in
0.1759547383	pah gene
0.1745323348	characterized by
0.1725926422	the hd gene
0.1721250927	to determine
0.1717452911	the mjd1
0.1716967815	the ald gene
0.1707828833	followed by
0.1703637650	n repeat
0.1699261151	lead to
0.1688894018	to date
0.1680234377	a single base
0.1676324023	the majority
0.1672221077	less than
0.1669540827	vhl gene
0.1663481732	exon 5
0.1633703049	molecular analysis of
0.1619970559	the ndp gene
0.1613521683	compatible with
0.1603139373	associated with
0.1597773873	intron 9
0.1596175329	gene mutations
0.1590137712	hdl c
0.1581748586	the expanded allele
0.1562450803	a subset
0.1552353314	the lesch nyhan syndrome
0.1542048458	trinucleotide repeat in
0.1537228297	evidence for
0.1502170033	the adenomatous polyposis coli
0.1485181850	point mutations in
0.1478475757	a frameshift mutation
0.1470725109	the proteolipid protein
0.1462644930	c terminal
0.1435214467	in vitro
0.1433587009	cancer families
0.1433185347	5 end
0.1432552630	molecular basis of
0.1427129735	protein gene
0.1421074800	a missense mutation
0.1407393100	coding region of
0.1404605773	report here
0.1403935939	plp gene
0.1395863313	the atm gene
0.1386975803	or ovarian cancer
0.1386443291	the polymerase chain reaction
0.1372599340	the vhl gene
0.1356994656	leads to
0.1354452211	exon 3
0.1351709099	in order to
0.1329665146	patients with
0.1325008133	appears to
0.1309976591	most likely
0.1296822206	protein s
0.1280184638	the dmd gene
0.1277044186	the rb1 gene
0.1275313306	the wild type
0.1275307587	exon 1
0.1270811289	exon 2
0.1265715361	a point mutation
0.1243680483	theta =
0.1241669624	the same
0.1241541490	contribute to
0.1234277481	effects on
0.1233363737	ndp gene
0.1224912943	t cell
0.1223133424	these findings
0.1217858631	the pah gene
0.1198102541	the plp gene
0.1194866177	gene responsible
0.1152051164	relationship between
0.1145094205	dmd gene
0.1132343272	cancer patients
0.1110763109	more than
0.1103397150	derived from
0.1098956935	missense mutations in
0.1086725932	hd gene
0.1082173161	= 0
0.1081342482	gene mutation
0.1078694204	atm gene
0.1078587276	at theta = 0
0.1068967794	led to
0.1064480129	on chromosome
0.1064187967	by means of
0.1056416267	thought to
0.1055925615	brca1 gene
0.1043904249	chromosome 5
0.1030863938	chromosome 12
0.1026567906	transition at
0.1025897269	common mutation
0.1024527609	at nt
0.1021048320	an increased risk
0.1017133372	the gene encoding
0.1011799270	g6pd deficiency in
0.1005655469	site mutation
0.1004687884	these results
0.0999731568	increased risk of
0.0978979464	the pax6 gene
0.0973016373	required for
0.0972174167	correlated with
0.0971880396	new variants
0.0971825539	brca1 mutations in
0.0969710017	at position
0.0963986671	ctg repeat in
0.0958616572	to investigate
0.0948750008	a single
0.0945354012	located within
0.0943898066	+ 0
0.0941027047	an expanded
0.0932862757	implications for
0.0931186606	the phenylalanine hydroxylase
0.0927779356	a nonsense mutation
0.0925531999	= 6
0.0923219138	at nucleotide
0.0915265890	these observations
0.0915152300	rise to
0.0915121308	absence of
0.0914666411	an autosomal
0.0911766020	boy with
0.0911178135	the presence of
0.0909177634	to identify
0.0908693868	encoded by
0.0906621428	characterization of
0.0906541369	the mutant allele
0.0897873363	child with
0.0889167557	susceptibility to
0.0887153465	direct sequencing of
0.0886523811	these data
0.0879009377	to detect
0.0874874702	the atm protein
0.0874629429	most frequent
0.0871201793	two point
0.0868932188	to assess
0.0867583219	in addition
0.0861621977	mutations in
0.0848504716	to define
0.0846890414	effect on
0.0846198579	ald gene
0.0846141120	this study
0.0843562378	result in
0.0841048770	result from
0.0836726084	obtained from
0.0834727496	more severe
0.0814359919	ability to
0.0803598048	families with
0.0802046515	resulting in
0.0799392069	the prader willi
0.0794798434	5 kb
0.0792234912	resulting from
0.0792215142	presenting with
0.0791423714	at risk
0.0785807490	at age
0.0783793088	to screen
0.0776025609	gene responsible for
0.0773199267	an x linked
0.0771773955	a family history
0.0770205890	a total of
0.0767496363	this mutation
0.0763022180	ovarian cancer in
0.0754953946	this family
0.0754385443	homozygous for
0.0750016506	type 2
0.0746471857	a key
0.0745736946	coding for
0.0743203054	missense mutation in
0.0743055260	compared with
0.0742268325	kinase gene
0.0741175052	report on
0.0741032041	in frame
0.0722040768	of glucose 6 phosphate dehydrogenase
0.0720875002	the ataxia telangiectasia
0.0714168273	detected by
0.0713951150	further evidence
0.0696591844	6 phosphate
0.0675485177	essential for
0.0671065344	untranslated region of
0.0670087174	with adult onset
0.0666911457	heterozygous for
0.0666402995	a strong
0.0662759794	appear to
0.0662463169	mapped to
0.0659407795	screened for
0.0658398995	homozygosity for
0.0657262812	confirmed by
0.0655332463	proximal to
0.0652171922	portion of
0.0649672728	a wide
0.0649101305	substitution at
0.0643108222	linkage between
0.0640118089	determination of
0.0639858254	defined by
0.0635283378	the polymerase chain
0.0634761671	distal to
0.0631356534	detected in
0.0631087081	analysis of
0.0627149475	basis for
0.0626520274	resulted in
0.0624355886	a maximum
0.0623288488	such as
0.0621171951	a large
0.0621130250	close to
0.0620288969	3 untranslated
0.0615668710	individuals with
0.0612004565	samples from
0.0610354624	this disorder
0.0597385281	identification of
0.0596064348	in exon 4
0.0592954755	maps to
0.0589337999	loss of
0.0588463020	proportion of
0.0588431084	an animal
0.0587519762	shown to
0.0587410421	exon 4
0.0583092787	model for
0.0581909214	linked to
0.0581311567	appeared to
0.0579893424	percentage of
0.0579382598	predisposition to
0.0577995241	response to
0.0577390511	but not
0.0574120684	women with
0.0572043752	c t
0.0571066553	involved in
0.0569395730	in contrast
0.0568715067	+ 1
0.0567714383	one allele
0.0567622291	found to
0.0567439668	heterozygotes for
0.0567099297	compared to
0.0564375789	at codon
0.0555488201	one family
0.0550833273	caused by mutations in
0.0549996678	identified as
0.0547534892	a t
0.0547376317	to determine whether
0.0545334536	an inherited
0.0543715400	homologous to
0.0537886969	expression of
0.0535111157	hex a
0.0530735678	1 phosphate
0.0529433878	similar to
0.0526829937	this region
0.0525384433	in man
0.0524272776	test for
0.0520309826	novel mutations
0.0519767174	markers on
0.0516902811	patient with
0.0513198647	mechanism for
0.0507784623	consequence of
0.0506110946	a patient with
0.0505459550	different mutations
0.0505345738	one patient
0.0497924404	deficiency of
0.0497867452	role for
0.0495671394	a novel mutation
0.0493053053	this report
0.0492386330	a t patients
0.0491972318	detection of
0.0486854070	the molecular basis
0.0486157918	role in
0.0485222919	form of
0.0484050695	determined by
0.0480999677	observed in
0.0476635128	present in
0.0463042249	predicted to
0.0457646638	isolated from
0.0454686690	an early
0.0454217615	family with
0.0453933267	the central nervous system
0.0452435116	manifestation of
0.0452304187	the gene for
0.0451943114	fibroblasts from
0.0451247384	evaluation of
0.0442925574	this patient
0.0441790872	subjects with
0.0440755607	three different
0.0438323112	possibility of
0.0437714044	member of
0.0435462065	mutation in
0.0434747731	dna from
0.0431108882	ability of
0.0429396265	affected by
0.0424579886	results in
0.0423972045	found in
0.0423969403	region of
0.0421883915	screening for
0.0421881313	not only
0.0421509588	estimated to
0.0420880075	studies on
0.0419641570	linkage to
0.0418105114	identified in
0.0416195905	localized to
0.0416127500	nature of
0.0414802736	deficiency in
0.0412972888	no evidence of
0.0411420266	sequencing of
0.0411373481	set of
0.0411317272	an increased risk of
0.0410793247	fraction of
0.0409374780	a family
0.0409319179	to occur
0.0409235543	defect in
0.0406725427	the same mutation
0.0406526269	presented with
0.0405247510	levels of
0.0405159314	cases of
0.0404932120	expansion of
0.0403026688	arm of
0.0402946779	identified by
0.0401177473	at least one
0.0400923719	results from
0.0400735021	features of
0.0400341358	the proband
0.0399512464	group of
0.0398976492	ratio of
0.0396747895	the 3 untranslated region
0.0396672127	amounts of
0.0396627896	alterations in
0.0393261339	part of
0.0393053637	two unrelated
0.0391291403	this population
0.0391071025	signs of
0.0390502314	to produce
0.0390129740	known as
0.0388994472	assignment of
0.0386492964	severity of
0.0384127956	a g to
0.0383672369	diagnosis of
0.0382201733	an increased
0.0381904359	combination of
0.0380749242	role of
0.0380656281	patients from
0.0379054915	implicated in
0.0376693192	isolation of
0.0375814143	relative to
0.0375052215	a result of
0.0373637633	identical to
0.0373552598	by use of
0.0369079346	history of
0.0364741425	carriers of
0.0364558141	localization of
0.0361893626	the hypothesis
0.0361016174	understanding of
0.0359833363	level of
0.0359521079	a significant
0.0358078833	degree of
0.0357206030	region on
0.0357072631	a variety of
0.0354816394	number of
0.0353081687	related to
0.0351862837	a rare
0.0351575175	the fact
0.0351228443	heterogeneity of
0.0350665824	these studies
0.0349579021	the basis of
0.0348704583	in vivo
0.0347129624	the result of
0.0345582797	a transition
0.0345521209	also identified
0.0344113019	but also
0.0343308817	organization of
0.0342227427	the first
0.0340386968	forms of
0.0340019868	all three
0.0338235607	expressed in
0.0338013394	likely to
0.0337758655	defects in
0.0333031029	effect of
0.0332911739	the possibility
0.0332510203	the x chromosome
0.0332338809	a novel
0.0330319041	frequency of
0.0329543959	risk for
0.0329007714	increase in
0.0326756024	transmission of
0.0326452557	rate of
0.0326192792	heterogeneity in
0.0325275492	in situ
0.0324894333	case of
0.0323933806	evidence of
0.0319962591	the majority of
0.0313892726	members of
0.0310788120	together with
0.0310784924	the frequency of
0.0308888155	individuals from
0.0308653754	comparison of
0.0307697894	regulation of
0.0307075068	affected with
0.0306731369	effects of
0.0305359897	a family with
0.0304540322	located in
0.0302550731	differences in
0.0302022796	no evidence
0.0301578511	the development of
0.0300568449	occur in
0.0298937305	involvement of
0.0298526824	not detected
0.0297263591	mutations at
0.0296276067	characteristic of
0.0296134610	cells from
0.0295269803	range of
0.0294874084	mapping of
0.0294704493	the c terminal
0.0294570131	in addition to
0.0294519172	series of
0.0292911087	deleted in
0.0292111908	homologue of
0.0291380851	end of
0.0287551114	most common
0.0286202823	distribution of
0.0284906864	the last
0.0284797943	incidence of
0.0284711837	the 3 untranslated
0.0284600548	reduction in
0.0282570144	lack of
0.0281799976	inheritance of
0.0281578511	the role of
0.0280972311	the 3 untranslated region of
0.0280178813	the occurrence of
0.0279471246	pattern of
0.0278245246	position of
0.0278234654	occurred in
0.0277834808	regions of
0.0277771844	prevalence of
0.0277698445	structure of
0.0277244135	spectrum of
0.0274386202	corresponding to
0.0274234923	analyzed for
0.0274084042	in contrast to
0.0273342148	the size of
0.0273256430	in association with
0.0271366184	seen in
0.0271165960	properties of
0.0271054099	a few
0.0268493663	the age of
0.0268142188	example of
0.0268007033	amplification of
0.0267910325	half of
0.0264916314	a new
0.0264134849	risk of
0.0263745385	a transition at
0.0263375061	no other
0.0263118173	accumulation of
0.0262519101	age at
0.0261583314	mutated in
0.0260930855	in response to
0.0260902255	the identification of
0.0259589327	the location of
0.0258313061	families from
0.0257763684	none of
0.0256254320	a member of
0.0254898596	examination of
0.0254498439	mutation at
0.0254003097	abnormalities in
0.0253656311	a number of
0.0251217278	types of
0.0251072008	inactivation of
0.0248417764	onset of
0.0247565426	a role for
0.0246969272	in exon 3
0.0246899028	the gene responsible for
0.0243219970	the molecular basis of
0.0239443103	association with
0.0238129320	a subset of
0.0237910504	change in
0.0237690512	a frameshift
0.0237501942	used to
0.0237257890	genes for
0.0235885552	a mutation in
0.0234285283	mutations within
0.0231478164	domains of
0.0231058932	a family history of
0.0230773191	at theta
0.0229701767	percent of
0.0226019227	duplication of
0.0224210596	basis of
0.0217884849	development of
0.0217140630	the risk of
0.0216105653	cause of
0.0214134849	domain of
0.0213153643	the level of
0.0210713138	the expression of
0.0208617334	as well
0.0207648855	known to
0.0206422181	changes in
0.0205932242	use of
0.0204586535	location of
0.0204528927	the absence of
0.0203428308	reported in
0.0203103018	characteristics of
0.0202847840	component of
0.0201795728	function of
0.0201429786	a candidate
0.0200054704	occurrence of
0.0199352240	map of
0.0197061146	a role in
0.0195149449	to carry
0.0192616701	the number of
0.0190892564	the diagnosis of
0.0189941929	formation of
0.0189854004	t mutation
0.0188479865	the effects of
0.0188029932	manifestations of
0.0187870000	locus on
0.0187078621	different from
0.0186098930	a deficiency of
0.0184431477	means of
0.0183176276	the loss of
0.0181716429	the regulation of
0.0181398711	the substitution of
0.0180893217	the function of
0.0176176052	a child
0.0175954053	a region of
0.0174842115	at onset
0.0173372583	contrast to
0.0171982454	score of
0.0169573506	substitution of
0.0169573506	site of
0.0166099566	the formation of
0.0163970338	result of
0.0159138723	size of
0.0148581949	a stop
0.0146434739	described in
0.0141313333	transition in
0.0139240494	the most
0.0121223091	an x
